10.40
0.23 (2.26%)
0.23 (2.26%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| TRACON Pharmaceuticals Inc | TCON | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.23 | 2.26% | 10.40 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.22 | 10.22 | 10.83 | 10.57 | 10.17 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 10.25 | 10.60 | 0.35 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,515 | 387,710 | $ 10.46 | $ 4,053,933 | 705,619 | 0.95 - 12.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:07 | formt | 200 | $ 10.40 | USD |
TRACON Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 151.10M | 14.53M | 14.48M | $ - | $ - | -7.47 | -3.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
TRACON Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TCON Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.97 | 11.49 | 9.51 | 10.63 | 637,488 | -0.57 | -5.2% |
| 1 Month | 8.15 | 12.20 | 7.83 | 10.19 | 777,484 | 2.25 | 27.61% |
| 3 Months | 5.05 | 12.20 | 4.41 | 8.46 | 836,990 | 5.35 | 105.94% |
| 6 Months | 1.88 | 12.20 | 1.48 | 4.81 | 1,202,805 | 8.52 | 453.19% |
| 1 Year | 3.86 | 12.20 | 0.95 | 4.30 | 779,847 | 6.54 | 169.43% |
| 3 Years | 3.10 | 12.20 | 0.2781 | 3.27 | 434,461 | 7.30 | 235.48% |
| 5 Years | 7.92 | 12.20 | 0.2781 | 3.33 | 290,298 | 2.48 | 31.31% |
TRACON Pharmaceuticals Description
| TRACON Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration (wet AMD). The company's pipeline consists of product candidates such as TRC105, TRC102, TRC253, TRC694, and TRC205. The lead product TRC105 is an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or programmed cell death protein 1 pathway. |
